vs
NETSOL TECHNOLOGIES INC(NTWK)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是NETSOL TECHNOLOGIES INC的1.9倍($35.5M vs $18.8M),NETSOL TECHNOLOGIES INC净利率更高(1.3% vs -304.2%,领先305.6%),RECURSION PHARMACEUTICALS, INC.同比增速更快(681.7% vs 21.1%),NETSOL TECHNOLOGIES INC自由现金流更多($-5.1M vs $-47.3M),过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高(60.5% vs 10.3%)
NETSOL科技公司是一家总部位于加利福尼亚州恩西诺的美国软件企业,核心业务为开发汽车租赁领域相关软件产品,为汽车租赁行业提供专业的数字化技术支持。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
NTWK vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.9倍
$18.8M
营收增速更快
RXRX
高出660.7%
21.1%
净利率更高
NTWK
高出305.6%
-304.2%
自由现金流更多
NTWK
多$42.2M
$-47.3M
两年增速更快
RXRX
近两年复合增速
10.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $18.8M | $35.5M |
| 净利润 | $246.8K | $-108.1M |
| 毛利率 | 48.0% | 59.8% |
| 营业利润率 | 6.9% | -304.8% |
| 净利率 | 1.3% | -304.2% |
| 营收同比 | 21.1% | 681.7% |
| 净利润同比 | 121.5% | 39.6% |
| 每股收益(稀释后) | $0.02 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
NTWK
RXRX
| Q4 25 | $18.8M | $35.5M | ||
| Q3 25 | $15.0M | $5.2M | ||
| Q2 25 | $18.4M | $19.2M | ||
| Q1 25 | $17.5M | $14.7M | ||
| Q4 24 | $15.5M | $4.5M | ||
| Q3 24 | $14.6M | $26.1M | ||
| Q2 24 | $16.4M | $14.4M | ||
| Q1 24 | $15.5M | $13.8M |
净利润
NTWK
RXRX
| Q4 25 | $246.8K | $-108.1M | ||
| Q3 25 | $-2.4M | $-162.3M | ||
| Q2 25 | $2.6M | $-171.9M | ||
| Q1 25 | $1.4M | $-202.5M | ||
| Q4 24 | $-1.1M | $-178.9M | ||
| Q3 24 | $70.8K | $-95.8M | ||
| Q2 24 | $-82.9K | $-97.5M | ||
| Q1 24 | $327.5K | $-91.4M |
毛利率
NTWK
RXRX
| Q4 25 | 48.0% | 59.8% | ||
| Q3 25 | 39.4% | -183.8% | ||
| Q2 25 | 56.2% | -4.9% | ||
| Q1 25 | 49.8% | -48.0% | ||
| Q4 24 | 44.5% | -181.4% | ||
| Q3 24 | 45.0% | 53.7% | ||
| Q2 24 | 51.5% | 36.2% | ||
| Q1 24 | 48.3% | 19.1% |
营业利润率
NTWK
RXRX
| Q4 25 | 6.9% | -304.8% | ||
| Q3 25 | -12.2% | -3327.6% | ||
| Q2 25 | 17.4% | -916.8% | ||
| Q1 25 | 8.9% | -1297.9% | ||
| Q4 24 | -3.1% | -4042.4% | ||
| Q3 24 | -5.2% | -377.1% | ||
| Q2 24 | 4.9% | -697.4% | ||
| Q1 24 | 8.5% | -698.4% |
净利率
NTWK
RXRX
| Q4 25 | 1.3% | -304.2% | ||
| Q3 25 | -15.7% | -3135.3% | ||
| Q2 25 | 14.0% | -894.2% | ||
| Q1 25 | 8.1% | -1373.3% | ||
| Q4 24 | -7.4% | -3935.5% | ||
| Q3 24 | 0.5% | -367.5% | ||
| Q2 24 | -0.5% | -676.6% | ||
| Q1 24 | 2.1% | -662.4% |
每股收益(稀释后)
NTWK
RXRX
| Q4 25 | $0.02 | $-0.17 | ||
| Q3 25 | $-0.20 | $-0.36 | ||
| Q2 25 | $0.22 | $-0.41 | ||
| Q1 25 | $0.12 | $-0.50 | ||
| Q4 24 | $-0.10 | $-0.56 | ||
| Q3 24 | $0.01 | $-0.34 | ||
| Q2 24 | $-0.01 | $-0.40 | ||
| Q1 24 | $0.03 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $18.1M | $743.3M |
| 总债务越低越好 | $337.0K | $9.6M |
| 股东权益账面价值 | $35.9M | $1.1B |
| 总资产 | $62.7M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.01× | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
NTWK
RXRX
| Q4 25 | $18.1M | $743.3M | ||
| Q3 25 | $22.7M | $659.8M | ||
| Q2 25 | $17.4M | $525.1M | ||
| Q1 25 | $18.8M | $500.5M | ||
| Q4 24 | $21.3M | $594.4M | ||
| Q3 24 | $24.5M | $427.6M | ||
| Q2 24 | $19.1M | $474.3M | ||
| Q1 24 | $12.3M | $296.3M |
总债务
NTWK
RXRX
| Q4 25 | $337.0K | $9.6M | ||
| Q3 25 | $218.2K | $11.9M | ||
| Q2 25 | $134.6K | $14.2M | ||
| Q1 25 | $86.8K | $16.4M | ||
| Q4 24 | $87.0K | $19.0M | ||
| Q3 24 | $92.6K | $20.5M | ||
| Q2 24 | $95.8K | $22.9M | ||
| Q1 24 | $130.4K | — |
股东权益
NTWK
RXRX
| Q4 25 | $35.9M | $1.1B | ||
| Q3 25 | $35.8M | $1.0B | ||
| Q2 25 | $37.8M | $919.1M | ||
| Q1 25 | $35.5M | $933.9M | ||
| Q4 24 | $33.9M | $1.0B | ||
| Q3 24 | $34.7M | $524.6M | ||
| Q2 24 | $34.8M | $584.4M | ||
| Q1 24 | $35.3M | $401.2M |
总资产
NTWK
RXRX
| Q4 25 | $62.7M | $1.5B | ||
| Q3 25 | $62.6M | $1.4B | ||
| Q2 25 | $62.4M | $1.3B | ||
| Q1 25 | $58.1M | $1.3B | ||
| Q4 24 | $59.1M | $1.4B | ||
| Q3 24 | $62.8M | $726.5M | ||
| Q2 24 | $64.2M | $775.9M | ||
| Q1 24 | $63.3M | $557.8M |
负债/权益比
NTWK
RXRX
| Q4 25 | 0.01× | 0.01× | ||
| Q3 25 | 0.01× | 0.01× | ||
| Q2 25 | 0.00× | 0.02× | ||
| Q1 25 | 0.00× | 0.02× | ||
| Q4 24 | 0.00× | 0.02× | ||
| Q3 24 | 0.00× | 0.04× | ||
| Q2 24 | 0.00× | 0.04× | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-4.7M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-5.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | -27.2% | -133.1% |
| 资本支出强度资本支出/营收 | 2.0% | 3.5% |
| 现金转化率经营现金流/净利润 | -19.24× | — |
| 过去12个月自由现金流最近4个季度 | $-1.0M | $-378.3M |
8季度趋势,按日历期对齐
经营现金流
NTWK
RXRX
| Q4 25 | $-4.7M | $-46.1M | ||
| Q3 25 | $5.3M | $-117.4M | ||
| Q2 25 | $441.0K | $-76.4M | ||
| Q1 25 | $-363.4K | $-132.0M | ||
| Q4 24 | $-5.1M | $-115.4M | ||
| Q3 24 | $5.5M | $-59.2M | ||
| Q2 24 | $6.5M | $-82.2M | ||
| Q1 24 | $-4.2M | $-102.3M |
自由现金流
NTWK
RXRX
| Q4 25 | $-5.1M | $-47.3M | ||
| Q3 25 | $4.8M | $-117.6M | ||
| Q2 25 | $-44.1K | $-79.6M | ||
| Q1 25 | $-693.0K | $-133.8M | ||
| Q4 24 | $-5.6M | $-116.7M | ||
| Q3 24 | $5.4M | $-63.8M | ||
| Q2 24 | $6.1M | $-83.4M | ||
| Q1 24 | $-4.6M | $-109.0M |
自由现金流率
NTWK
RXRX
| Q4 25 | -27.2% | -133.1% | ||
| Q3 25 | 32.1% | -2272.5% | ||
| Q2 25 | -0.2% | -413.9% | ||
| Q1 25 | -4.0% | -907.4% | ||
| Q4 24 | -36.1% | -2567.7% | ||
| Q3 24 | 37.1% | -244.6% | ||
| Q2 24 | 37.0% | -578.5% | ||
| Q1 24 | -29.6% | -789.9% |
资本支出强度
NTWK
RXRX
| Q4 25 | 2.0% | 3.5% | ||
| Q3 25 | 3.2% | 4.7% | ||
| Q2 25 | 2.6% | 16.4% | ||
| Q1 25 | 1.9% | 12.4% | ||
| Q4 24 | 3.0% | 28.6% | ||
| Q3 24 | 0.7% | 17.5% | ||
| Q2 24 | 2.6% | 8.2% | ||
| Q1 24 | 2.4% | 48.2% |
现金转化率
NTWK
RXRX
| Q4 25 | -19.24× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | -0.26× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 77.94× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -12.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NTWK
| Core Revenue | $18.0M | 96% |
| Other | $816.8K | 4% |
RXRX
暂无分部数据